Deal Flurry Shows Drug Makers’ Swing Toward Specialization April 29, 2014 6:00am by Barry Ritholtz Source: WSJ Spread the wealth. twitter facebook linkedin What's been said: Discussions found on the web: Posted UnderUncategorized Previous Post Interpreting Deviations from Okun’s Law Next Post Spec-Tech Crash Is a Good Thing
What's been said:
Discussions found on the web: